Edgestream Partners, L.P. Axsome Therapeutics, Inc. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 69,961 shares of AXSM stock, worth $9.32 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
69,961
Previous 70,086
0.18%
Holding current value
$9.32 Million
Previous $8.17 Million
10.66%
% of portfolio
0.21%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
410Shares Held
37.4MCall Options Held
510KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$439 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$225 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$202 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$151 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...